Vloga farmacevta na kliničnem oddelku Psihiatrične bolnišnice Vojnik pri izboljšanju bolnikovega razumevanja zdravljenja z zdravili za zdravljenje duševnih motenj

Šrot, Neža (avtor), Kerec Kos, Mojca (mentor), Hriberšek, Danila (komentor)

Pri psihiatričnih bolnikih se stopnja sodelovanja pri zdravljenju z zdravili giblje med 20 % in 60 %, kar pogosto vodi v poslabšanje simptomov, večjo verjetnost ponovne hospitalizacije in slabši izid zdravljenja. Eden pomembnih dejavnikov, ki vplivajo na sodelovanje bolnikov pri zdravljenju z zdravili, je bolnikovo razumevanje bolezni in zdravljenja. Namen prospektivne raziskave, ki smo jo izvedli v Psihiatrični bolnišnici Vojnik, je bil oceniti vpliv farmacevtske obravnave na bolnikovo razumevanje zdravljenja z zdravili za zdravljenje duševnih motenj. Za oceno razumevanja zdravljenja z zdravili smo uporabili vprašalnik, ki smo ga sami oblikovali. Uporabili smo ga med hospitalizacijo (pred obravnavo farmacevta), ter po farmacevtski obravnavi (ob odpustu in dva tedna po odpustu). V raziskavo smo vključili 26 bolnikov iz treh oddelkov, od tega 10 žensk in 16 moških. Povprečna starost bolnikov je bila 42,7 let. Najmlajši bolnik je bil star 22, najstarejši pa 68 let. Najpogostejše diagnoze so bile iz skupine Shizofrenija, shizotipske in blodnjave motnje, sledijo Razpoloženjske motnje in nato Nevrotske, stresne in somatoformne motnje. Mediana števila zdravil za zdravljenje duševnih motenj na bolnika je bila med hospitalizacijo 5, ob odpustu in dva tedna po odpustu pa 4. Delež bolnikov, ki so menili, da poznajo vsa predpisana zdravila, se je dvignil iz 76,9 % med hospitalizacijo na 92,3 % ob odpustu, ta delež pa se je ohranil tudi dva tedna po odpustu. Bolniki so med hospitalizacijo za 58,4 % svojih zdravil za zdravljenje duševnih motenj opredelili, da jim pomagajo. Ob odpustu se je ta delež dvignil na 90,1 %, po dveh tednih pa na 99,2 %. Obravnava je vplivala tudi na jemanje zdravil. Med hospitalizacijo je 19,2 % bolnikov poročalo, da so v zadnjem mesecu sami prenehali jemati zdravilo zaradi neželenih učinkov, brez posveta z zdravnikom. Dva tedna po odpustu ni nihče poročal o samostojni prekinitvi zdravljenja. To kaže na pomembno zmanjšanje nenadzorovanega prekinjanja zdravljenja, ki sicer predstavlja veliko tveganje za poslabšanje bolezni in ponovno hospitalizacijo. Hkrati je 57,7 % bolnikov med hospitalizacijo poročalo, da jim pogovor s farmacevtom zmanjšuje strah pred zdravili, ob odpustu 88,5 %, po dveh tednih pa 76,9 %. Rezultati nakazujejo, da obravnava farmacevta izboljša bolnikovo razumevanje zdravil in bolezni, kar nakazuje na pomembno vlogo farmacevta pri zagotavljanju kontinuiranega in kakovostnega zdravljenja z zdravili tudi po odpustu iz bolnišnice.

• Jezik: Slovenski jezik
• Ključne besede: obravnava farmacevta, duševne motnje, zdravila za zdravljenje duševnih motenj, sodelovanje pri zdravljenju, razumevanje zdravljenja
• Vrsta gradiva: Magistrsko delo/naloga
• Tipologija: 2.09 - Magistrsko delo
• Organizacija: FFA - Fakulteta za farmacijo
• Leto izida: 2025
• PID: 20.500.12556/RUL-176409
• COBISS.SI-ID: 259836931
• Datum objave v RUL: 29.11.2025

Sekundarni jezik

• Jezik: Angleški jezik
• Naslov: The role of a pharmacist in the clinical department of the Psychiatric Hospital Vojnik in improving patients' understanding of pharmacological treatment for mental disorders

Izvleček

In psychiatric patients, the rate of adherence to pharmacological treatment ranges between 20% and 60%, often resulting in symptom deterioration, an increased risk of rehospitalization, and poorer treatment outcomes. One of the key factors influencing adherence to medication is patients’ understanding of their illness and the treatment process. The aim of this prospective study conducted at the Vojnik Psychiatric Hospital was to assess the impact of a pharmacist’s intervention on patients’ understanding of medication treatment for mental disorders. A custom-designed questionnaire was used during hospitalization (before the pharmacist’s intervention), at discharge, and two weeks post-discharge. The study included 26 patients from three wards, of whom 10 were females and 16 males. The average age was 42.7 years. The youngest patient was 22 years old and the oldest was 68. The most common diagnoses were within the group of Schizophrenia, schizotypal and delusional disorders, followed by Mood disorders, and then Neurotic, stress-related, and somatoform disorders. The median number of medications for the treatment of mental disorders per patient was 5 during hospitalization and 4 at discharge and two weeks after discharge.The proportion of patients who believed they were familiar with all their prescribed medications increased from 76.9% during hospitalization to 92.3% at discharge, and this level was maintained two weeks after discharge. During hospitalization, patients identified 58.4% of their psychiatric medications as helpful. This increased to 90.1% at discharge, and to 99.2% two weeks later. The intervention also affected medication adherence. During hospitalization, 19.2% of patients reported independently stopping their medication due to side effects in the previous month without consulting a doctor. Two weeks after discharge, none reported such behaviour. This indicates a significant reduction in unsupervised treatment discontinuation, which otherwise poses a major risk of illness worsening and rehospitalization. At the same time, 57.7% of patients reported during hospitalization that a conversation with the pharmacist reduced their fear of medication; this increased to 88.5% at discharge and was 76.9% two weeks later. The results suggest that pharmacist intervention improves patients’ understanding of their medications and illness, indicating the important role of pharmacists in ensuring continuous and high-quality treatment even after hospital discharge.

• Ključne besede: pharmacist intervention, mental disorders, psychiatric medications, treatment adherence, treatment understanding